Free To Breathe

Calendula, Eucalyptus,peppermint


Sierra Sage Herbs Llc
Human Otc Drug
NDC 70994-109
Free To Breathe also known as Calendula, Eucalyptus,peppermint is a human otc drug labeled by 'Sierra Sage Herbs Llc'. National Drug Code (NDC) number for Free To Breathe is 70994-109. This drug is available in dosage form of Salve. The names of the active, medicinal ingredients in Free To Breathe drug includes Calendula Officinalis Flower - 1 [hp_X]/100g Eucalyptus Globulus Leaf - 1.63 g/100g Mentha Piperita - 1.63 g/100g . The currest status of Free To Breathe drug is Active.

Drug Information:

Drug NDC: 70994-109
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Free To Breathe
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Calendula, Eucalyptus,peppermint
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Sierra Sage Herbs Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Salve
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CALENDULA OFFICINALIS FLOWER - 1 [hp_X]/100g
EUCALYPTUS GLOBULUS LEAF - 1.63 g/100g
MENTHA PIPERITA - 1.63 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 06 Mar, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 14 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Sierra Sage Herbs LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0852633003053
UPC stands for Universal Product Code.
UNII:P0M7O4Y7YD
S546YLW6E6
79M2M2UDA9
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
70994-109-011 CAN in 1 BOX (70994-109-01) / 19.8 g in 1 CAN (70994-109-09)06 Mar, 2020N/ANo
70994-109-0417 g in 1 TUBE (70994-109-04)06 Mar, 2020N/ANo
70994-109-08113.4 g in 1 JAR (70994-109-08)06 Mar, 2020N/ANo
70994-109-101 CAN in 1 BOX (70994-109-10) / 51.7 g in 1 CAN (70994-109-02)06 Mar, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose skin protectant cough suppressant topical analgesic

Product Elements:

Free to breathe calendula, eucalyptus,peppermint sunflower oil calendula officinalis flower calendula officinalis flower lavender oil cryptocarya agathophylla leaf oil olive oil alpha-tocopherol eucalyptus globulus leaf eucalyptus globulus leaf rosemary oil yellow wax castor oil mentha piperita mentha piperita

Indications and Usage:

Indications & usage ■ helps prevent and temporarily protects and helps relieve ■ chapped or cracked skin ■ when applied to the chest, throat, and bottom of feet, temporarily relieves cough due to minor throat and bronchial irritation associated with a cold ■ temporarily relieves minor aches and pains of muscles and joints

Warnings:

Warnings warnings for external use only. do not use on ■ on deep wounds ■ serious burns ■ by mouth ■ in nostrils ■ with tight bandages ■ with heat ■ in a vaporizor avoid contact with eyes. rinse with water to remove eyes. rinse with water to remove. stop use and ask a doctor if you ■ nasal congestion gets worse ■ condition worsens ■ symptoms last more than 7 days or clears up and occurs again within a few days ask doctore before use if you ■ have cough with excessive mucus ■ persistent or chronic cough such as occurs with smoking, asthma, or emphysema ■ if pregnant or breast-feeding ■ children under 2 years

Dosage and Administration:

Dosage & administration rub gently on chest, neck or bottom of the feet. apply 2-3 times a day.

Package Label Principal Display Panel:

Principal display panel free to breathe hanger


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.